GlassScriptPhysician profile
Leena S John
NPI 1811254907
$5,458.20
in general payments reported to CMS, 2019-2025
40 companies · $1,802 in 2025
The $1,802 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $657 · 2022: $755 · 2023: $903 · 2024: $1,341 · 2025: $1,802.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,046.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,045.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $674.21 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $516.78 | 2021-2025 | |
| Astellas Pharma US INC | $472.91 | 2021-2025 | Xtandi, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $405.19 | 2021-2025 | |
| Endo Pharmaceuticals INC. | $363.81 | 2021-2024 | Xiaflex, Aveed |
| Medtronic, INC. | $335.63 | 2021-2025 | Interstim |
| Endo USA, INC. | $243.50 | 2024-2025 | Xiaflex, Aveed |
| Myriad Genetic Laboratories, INC. | $238.46 | 2021-2025 | Prolaris |
| Boston Scientific Corporation | $182.34 | 2021-2025 | General - Therapies, Ams 700 |
| Urogen Pharma, INC. | $169.51 | 2025 | |
| Verity Pharmaceuticals INC. | $168.21 | 2025 | Trelstar, Tlando |
| Janssen Biotech, INC. | $144.41 | 2021-2025 | Erleada, Akeega |
| Blue Earth Diagnostics | $137.82 | 2021-2022 | |
| Axonics, INC. | $126.75 | 2021-2023 | Axonics |
| Merck Sharp & Dohme LLC | $117.73 | 2023-2025 | Keytruda, Welireg, Lynparza |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $116.11 | 2025 | Eligard, Jatenzo |
| Dentsply Ih Ab | $114.95 | 2023-2025 | Lofric, Lofric |
| Astrazeneca Pharmaceuticals LP | $95.32 | 2021-2025 | Lynparza |
| Urovant Sciences INC | $94.93 | 2021-2022 | |
| C. R. Bard, INC. & Subsidiaries | $73.39 | 2024-2025 | Bard Urinary Drainage Bag |
| Angiodynamics, INC. | $67.71 | 2022 | |
| 180 Medical, INC. | $58.02 | 2022 | |
| Stryker Corporation | $52.99 | 2024 | 1788 |
| Antares Pharma, INC. | $52.42 | 2021-2024 | Xyosted, Nocdurna, Tlando |
| Pfizer INC. | $51.57 | 2021 | |
| Olympus America INC. | $49.95 | 2022-2025 | Itind System |
| Smith+Nephew, INC. | $46.78 | 2025 | Grafix, Stravix |
| Myovant Sciences INC. | $43.94 | 2021-2022 | |
| Ambu INC. | $34.96 | 2024 | |
| Dendreon Pharmaceuticals LLC | $32.99 | 2024 | Provenge |
| Teleflex LLC | $25.03 | 2023 | Urolift |
| Calyxo, INC. | $22.40 | 2024 | Cvac Aspiration System |
| Progenics Pharmaceuticals, INC. | $19.87 | 2021 | |
| Lsi Solutions INC | $18.91 | 2024 | Jnw Urtrac |
| Sun Pharmaceutical Industries INC. | $18.63 | 2024 | |
| Agiliti Surgical, INC. | $17.62 | 2023 | Trinity, Sonablate |
| Tolmar Pharmaceuticals, INC. | $14.96 | 2021 | |
| Civco Medical Instruments | $13.88 | 2024 | |
| Dentsply Ih INC. | $12.84 | 2021 | |
| Laborie Medical Technologies Corp. | $10.77 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leena John listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.